A report detailing three cases of advanced cancer (breast, prostate, and melanoma) where patients achieved remission after adding Fenbendazole to their regimens. Fenbendazole as an Anticancer Agent? A Case Series .
However, the primary research paper often cited by that community regarding the drug's potential anti-cancer mechanisms is:
It promotes the activation of the p53 tumor suppressor protein, leading to programmed cell death (apoptosis). Other Notable Papers Fenbendazole.org intersect.rar
Research indicating that the drug may target cancer stem cells, which are often resistant to standard treatments. Fenbendazole Exhibits Antitumor Activity Against Cervical Cancer .
An overview of the pharmacokinetics and promising biological activities for cancer therapy in both humans and animals. Oral Fenbendazole for Cancer Therapy . A report detailing three cases of advanced cancer
Source: Nature Scientific Reports / PubMed Central Date: August 9, 2018 Key Findings:
The American Cancer Society and other health authorities emphasize that while laboratory studies exist, Fenbendazole is not FDA-approved for human use, and large-scale clinical trials are still needed to confirm its safety and efficacy in people. However, the primary research paper often cited by
If you are looking for specific types of data, these recent publications are frequently referenced: